Molecular Partners Ag (MOLN) Return on Equity [ROE] (2022 - 2026)
Molecular Partners Ag (MOLN) recorded Return on Equity [ROE] of -95.81% in Q3 2026, down 39.49 percentage points from -56.32% a year earlier and down 14.00 percentage points from the prior quarter.
Powered by 
Analysis
Molecular Partners Ag (MOLN) Return on Equity [ROE] (2022 - 2026) Analysis & Trends
For FY2025, Molecular Partners Ag reported Return on Equity [ROE] of -57.58%, down 24.01 percentage points from FY2024.
- Annual Return on Equity [ROE] has declined for three straight years, though with a four-year change of +0.82 percentage points (FY2021 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at -33.57% in FY2024 (-3.82 pp), -29.75% in FY2023 (-96.12 pp), 66.38% in FY2022 (+124.78 pp) and -58.40% in FY2021.
- The Q3 2026 figure is the lowest quarterly Return on Equity [ROE] in data going back to Q4 2021.
- On a year-over-year basis, Return on Equity [ROE] has declined for 12 consecutive quarters, with an average year-over-year change of -22.35 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 104.39 percentage points in Q4 2022, against a drop of 81.90 percentage points in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -81.81% (Q2 2026), -77.14% (Q1 2026) and -66.89% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Molecular Partners Ag | 125.16 Mn | -243.89 Mn | - | -95.81% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -95.81% |
| Jun 30, 2026 | -81.81% |
| Mar 31, 2026 | -77.14% |
| Dec 31, 2025 | -66.89% |
| Sep 30, 2025 | -56.32% |
| Jun 30, 2025 | -54.97% |
| Mar 31, 2025 | -45.48% |
| Dec 31, 2024 | -39.19% |
| Sep 30, 2024 | -42.34% |
| Jun 30, 2024 | -35.51% |
| Mar 31, 2024 | -32.84% |
| Dec 31, 2023 | -32.13% |
| Sep 30, 2023 | -31.69% |
| Jun 30, 2023 | -30.81% |
| Mar 31, 2023 | -23.97% |
| Dec 31, 2022 | 48.69% |
API Access
Molecular Partners Ag Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MOLN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "MOLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MOLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();